Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$120.64B
Total volume
BTC 49.88%     ETH 15.33%
Dominance

Codexis CDXS Stock

3.48 USD {{ price }} -0.853484% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
244.66M USD
LOW - HIGH [24H]
3.48 - 3.72 USD
VOLUME [24H]
302.36K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.12 USD

Codexis Price Chart

Codexis CDXS Financial and Trading Overview

Codexis stock price 3.48 USD
Previous Close 2.76 USD
Open 2.73 USD
Bid 0 USD x 1800
Ask 0 USD x 1800
Day's Range 2.71 - 2.91 USD
52 Week Range 2.19 - 13.03 USD
Volume 782.78K USD
Avg. Volume 847.91K USD
Market Cap 191.62M USD
Beta (5Y Monthly) 1.636619
PE Ratio (TTM) N/A
EPS (TTM) -1.12 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 11.14 USD

CDXS Valuation Measures

Enterprise Value 123.78M USD
Trailing P/E N/A
Forward P/E -3.0210526
PEG Ratio (5 yr expected) -0.16
Price/Sales (ttm) 1.6486278
Price/Book (mrq) 1.5193223
Enterprise Value/Revenue 1.065
Enterprise Value/EBITDA -3.001

Trading Information

Codexis Stock Price History

Beta (5Y Monthly) 1.636619
52-Week Change -68.28%
S&P500 52-Week Change 20.43%
52 Week High 13.03 USD
52 Week Low 2.19 USD
50-Day Moving Average 3.29 USD
200-Day Moving Average 5 USD

CDXS Share Statistics

Avg. Volume (3 month) 847.91K USD
Avg. Daily Volume (10-Days) 1.14M USD
Shares Outstanding 66.77M
Float 59.99M
Short Ratio 3.84
% Held by Insiders 3.00%
% Held by Institutions 94.97%
Shares Short 3.92M
Short % of Float 6.01%
Short % of Shares Outstanding 5.87%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -41.16%
Operating Margin (ttm) -40.36%
Gross Margin 4.25%
EBITDA Margin -35.48%

Management Effectiveness

Return on Assets (ttm) -12.93%
Return on Equity (ttm) -33.62%

Income Statement

Revenue (ttm) 116.23M USD
Revenue Per Share (ttm) 1.77 USD
Quarterly Revenue Growth (yoy) -63.29%
Gross Profit (ttm) 20.46M USD
EBITDA -41250000 USD
Net Income Avi to Common (ttm) -47853000 USD
Diluted EPS (ttm) -0.69
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 102.83M USD
Total Cash Per Share (mrq) 1.54 USD
Total Debt (mrq) 42.34M USD
Total Debt/Equity (mrq) 33.6 USD
Current Ratio (mrq) 3.392
Book Value Per Share (mrq) 1.889

Cash Flow Statement

Operating Cash Flow (ttm) 13.26M USD
Levered Free Cash Flow (ttm) 20.71M USD

Profile of Codexis

Country United States
State CA
City Redwood City
Address 200 Penobscot Drive
ZIP 94063
Phone 650 421 8100
Website https://www.codexis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 248

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Q&A For Codexis Stock

What is a current CDXS stock price?

Codexis CDXS stock price today per share is 3.48 USD.

How to purchase Codexis stock?

You can buy CDXS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Codexis?

The stock symbol or ticker of Codexis is CDXS.

Which industry does the Codexis company belong to?

The Codexis industry is Biotechnology.

How many shares does Codexis have in circulation?

The max supply of Codexis shares is 70.3M.

What is Codexis Price to Earnings Ratio (PE Ratio)?

Codexis PE Ratio is now.

What was Codexis earnings per share over the trailing 12 months (TTM)?

Codexis EPS is -1.12 USD over the trailing 12 months.

Which sector does the Codexis company belong to?

The Codexis sector is Healthcare.

Codexis CDXS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16379.46 USD
-0.12
4.71B USD 16347.38 USD 16420.92 USD 4.71B USD
NASDAQ Global Select Market Com NQGS 7966.15 USD
-0.13
7950.14 USD 7986.36 USD
NASDAQ Biotechnology NBI 4429.97 USD
-0.36
4426.59 USD 4461.88 USD
NASDAQ HealthCare IXHC 1011.84 USD
-0.04
1011.35 USD 1017.55 USD
NASDAQ Composite Total Return I XCMP 19904.22 USD
-0.12
19865.24 USD 19954.6 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Industrial INDS 9864.66 USD
-0.02
9854.04 USD 9893.53 USD